Introduction {#sec1-1}
============

The management of acute ischemic stroke has undergone a sea of change with the introduction of intravenous thrombolysis (IVT). In the NINDS\[[@ref1]\] trial, a clear benefit was found in patients who were treated with IVT within the first 3 hours. Following the results of the ECASS 3\[[@ref2]\] trial, the window period for IVT was extended to 4.5 hours.

As per the PROACT\[[@ref3]\] trial, patients of acute ischemic stroke with a middle cerebral artery occlusion may be treated using intraarterial thrombolysis within 6 h. The MERCI,\[[@ref4]\] Multi Merci,\[[@ref5]\] and Penumbra\[[@ref6]\] trials showed better recanalisation in patients having large vessel occlusion who were treated with endovascular therapy. Recently published data from three large trials, IMS 3,\[[@ref7]\] Synthesis Expanision,\[[@ref8]\] and MR rescue\[[@ref9]\] failed to demonstarte the superiority of endovascular treatment over IVT. In these trials, stent retrievers were used in very few patients. However, according to SWIFT\[[@ref10]\] trial stent retrievers have better recanalisation rates and therefore, better outcomes. We present our results, from a tertiary care center in Bangalore, comparing the outcomes in patients of acute ischemic stroke treated with IVT versus those treated using endovascular therapy. The endovascular treatment was done by a interventional neurologist and in a majority of cases stent retrievers were used.

The stroke protocol followed in our institute is described in [Figure 1](#F1){ref-type="fig"}. All patients with acute stroke undergo a baseline imaging, comprising of either a computed tomography (CT) with CT angiogram or a magnetic resonance imaging (MRI) imaging with stroke protocol. This comprises of a diffusion sequence, an ADC, T2, FLAIR, and a TOF angio of neck and intracranial vessels. As the MRI is more time consuming, it was reserved for patients who presented with a wake up stroke or patients with posterior circulation stroke who presented beyond the window period. Thus in all patients with acute ischemic stroke, an angiogram of neck and intracranial vessels was available before starting thrombolysis.

![Stroke Protocol followed at our institute](JNRP-5-25-g001){#F1}

If the angiogram was normal, patients were given IVT. If the angiogram showed a large vessel occlusion along with either contraindications for IVT or no improvement with IVT, then they were taken for endovascular therapy. In some cases, before the IMS3 results, few patients were taken directly for endovascular treatment after taking informed consent from the patients relatives.

We compared the results of patients who underwent IVT with those of patients who underwent endovascular therapy. This study also compared the outcomes of patients with large vessel occlusion who were treated with endovascular therapy with those who received IVT.

Materials and Methods {#sec1-2}
=====================

Patients with acute ischemic stroke presenting to our institute who underwent thrombolysis were included in this study. In total, 53 patients were thrombolysed between 2010 and 2012; 23 received IVT and 30 were taken up for endovascular treatment. We present an analysis of their outcome.

Patients were divided into two groups depending on whether they received intavenous thrombolysis or endovascular treatment. They were analysed based on their National Institutes of Health Stroke Scale (NIHSS) on admission, time from onset of symptoms, door to needle time, stroke subtype, modified Rankin Scale (mRS), and mortality at 90 days.

The outcome of the patients who received IVT was analysed based on angiogram results showing normal study or on an evidence of a large vessel occlusion.

We also compared the outcomes of patients who received IVT, in presence of documented large vessel disease to the outcomes of patients who underwent endovascular treatment.

Of the 30 patients of the endovascular group, 23 patients underwent endovascular therapy within 4.5 h from the onset of symptoms, that is, the window period for IVT. The outcome in these patients was compared with those patients who received IVT in the presence of a large vessel occlusion.

Tabulated results were analysed using INSTAT Graphpad analyser. Data were analysed using paired and unpaired *t*-test, Chi-square test, and Fishers test as applicable. *P* value was considered significant when it was less than 0.05.

Results {#sec1-3}
=======

A total of 53 patients underwent thrombolysis between 2010 and 2012; 23 patients underwent IVT and 30 patients underwent endovascular treatment \[[Table 1](#T1){ref-type="table"}\].

###### 

Comparision of intravenous group and intervention group

![](JNRP-5-25-g002)

The patients who received IVT were subdivided on the basis of their CT/MR angiograms into those having a normal angiogram and those with evidence of a large vessel occlusion. Out of the 23 patients, 14 had a normal baseline angiogram. Nine patients had documented large vessel disease. Among the nine patients with documented large vessel, four patients had cross flow on their angiogram (CT or MR angiogram) \[[Table 2](#T2){ref-type="table"}\].

###### 

Comparision of patients who underwent IVT with or without large vessel occlusion
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Further, we compared the patients who underwent IVT in the presence of documented large vessel disease with the patients of the endovascular group \[[Table 3](#T3){ref-type="table"}\].

###### 

Comparision of patients with large vessel occlusion who underwent IVT with endovascular treatment

![](JNRP-5-25-g004)

Outcomes of patients who received endovascular treatment within 4.5 h and of the intravenous group patients with documented large vessel disease were compared \[[Table 4](#T4){ref-type="table"}\].

###### 

Comparison of patients with large vessel occlusion within 4.5 hrs of stroke onset

![](JNRP-5-25-g005)

Discussion {#sec1-4}
==========

A total of 53 patients with acute ischemic stroke underwent thrombolysis between 2010 and 2012; 30 patients underwent endovascular treatment and 23 underwent IVT. Nine of the patients who underwent IVT had a large vessel occlusion. Patients with occlusion of one internal carotid artery were considered as having good cross flow if the MCA was filled through anterior communicating artery (ACOM) or posterior communicating artery (PCOM) (Willisian Collaterals) \[Figures [2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}\]. Four of nine patients had a documented cross flow.

![TOF MR angiogram of a patient demonstrating cross flow. The Right ICA is occluded, right MCA and ACA filling through ACOM](JNRP-5-25-g006){#F2}

![TOF MR angiogram showing ICA occluded with no evidence of cross flow](JNRP-5-25-g007){#F3}

In the earlier part of our study, stent retrievers were used only if there was no recanalization after intraarterial injection of 20 mg of rTPA (Recombinant tissue plasminogen activator). Toward the later part of our study, stent retrievers (Solitaire) were used as primary modality of endovascular treatment. Two patients who underwent endovascular treatment were initially given intravenous rTPA (bridging thrombolysis). Stent retrievers (Solitaire) were used in 21 out of 30 patients during the study. The nine patients who underwent IVT in the presence of large vessel occlusion were not taken for endovascular therapy, primarily because the relatives did not give consent. The main constraint was financial.

A statistically significant difference was found between the median NIHSS on admission in the endovascular group (median NIHSS 20) and the intravenous group (median NIHSS 14). The 'door to needle' time in the endovascular group was 117.50 min versus 66.25 min in the intravenous group. This difference was also statistically significant. Despite the significant difference in the NIHSS on admission and in 'door to needle' time, there were no statistically significant differences between the two groups in the median mRS at 90 days follow up (3 in the intravenous group and 0.5 in the endovascular group) and in the 90 days mortality rate. Two patients in the study had a symptomatic intracerebral hemorrhage; both were in the intravenous group.

In the intravenous group, the NIHSS on admission was statistically higher in the patients who had a large vessel occlusion (median NIHSS 20) as compared with those who had a normal angiogram (median NIHSS 11), suggesting that the patients with large vessel occlusion had a more severe stroke. On comparing the outcomes between these two subgroups, the median mRS achieved by the nine patients with large vessel occlusion was 3 as compared with a median mRS of 1 achieved by patients with a normal angiogram. This difference was not statistically significant. Three of the 9 patients (33%) with large vessel occlusion and 2 of the 14 patients (14%) with a normal angiogram were dead at 90 days follow-up. These findings are summarized in [Table 2](#T2){ref-type="table"}.

Comparing the endovascular group with the patients who received IVT in the presence of large vessel occlusion, the median NIHSS was 20 in both groups. The median mRS at 90 days was 0.5 in the endovascular group and 3 in the intravenous group. A total of 63% of the endovascular group achieved a mRS of \<2 as compared with the intravenous group in which 44% achieved a mRS of \<2 at 90 days follow up. The mortality in the endovascular group was 16% (5 out of 30) as compared with 33% (3 out of 9) in the intravenous group with large vessel occlusion. There was no statistical difference in the outcomes between the two groups.

Of the 30 patients, 23 in the endovascular group were treated within 4.5 h, that is, the window period for IVT. Of these 23 patients, 2 received IVT prior to being taken for endovascular treatment. The remaining received endovascular treatment as many had contraindications for IVT, while a few were taken directly for endovascular therapy, before the IMS3 results were published. We compared this subset of patients with the patients who received IVT in the presence of large vessel occlusion. The therapy in these patients was also within 4.5 h. The median mRS in the endovascular group was 0.5 as compared with the intravenous group, which was 3. This difference was found to be statistically significant. A total of 82% (19 out of 23 patients) had a mRS of 2 or less at 90 days in the endovascular group as compared with 44% (4 out of 9) in the intravenous group. In four out of nine patients in the intravenous group with large vessel occlusion, there was no cross flow through Willisian collaterals. None of these patients achieved a mRS of \<2 at 90 days follow up as compared with the 19 out of 23 patients in the endovascular group. This difference was found to be statistically significant.

In the IMS3\[[@ref7]\] trial, patients were randomly assigned to receive intervention following intravenous TPA and compared with patients who received intravenous TPA alone. They concluded that there was no improvement in functional independence in patients who had received only intravenous TPA or patients who had received intravenous TPA as well as intervention treatment. In the Synthesis Trial,\[[@ref8]\] patients were randomly assigned to be treated by IVT or intervention. The intervention modality used was intraarterial thrombolysis, mechanical, or a combination of both. It was concluded that there was no difference between the two groups. In both of these trials, vessel status was not documented in all patients. Stent retrievers were used only in a few patients.

In this study, patients who received endovascular therapy fared just as well as those who received intravenous therapy in spite of having a significantly higher NIHSS, longer duration of stroke, and a higher 'door to needle' time. The mortality rates remained similar between the two groups.

Patients who underwent IVT with documented large vessel disease, with no cross flow on angiogram fared poorly as compared with patients treated with endovascular modalities.

In patients treated within 4.5 h of symptom onset, the endovascular group had a better outcome compared with intravenous group with documented large vessel disease.

It is recommended that all patients presenting with acute ischemic stroke in the window period should have baseline angiogram either CT with angiogram or MRI with angiogram.

Patients with no large vessel occlusion should undergo IVT.

However, patients who have documented M1, carotid T, or basilar occlusion should be considered for endovascular treatment as early as possible if they fail IVT or have contraindications for IVT.

The limitation of this study was that it was an observational nonrandomized study with a small sample size.

Further studies with larger statistical sample size are needed to confirm the added benefit of endovascular treatment using stent retrievers in patients with documented large vessel disease. Demonstration of large vessel occlusion along with NIHSS should be considered criteria for randomization.
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